welcome
The Motley Fool

The Motley Fool

Health

Health

1 Stock Worth Buying Near Its 52-Week Low, According to Wall Street

The Motley Fool
Summary
Nutrition label

66% Informative

Iovance Biotherapeutics develops therapies that harness the power of tumor-infiltrating lymphocytes (TILs), immune cells that can target and destroy cancer cells.

The company's Amtagvi , a medicine for melanoma that earned approval from the U.S. last year , takes 34 days to manufacture.

Stock Advisor’s total average return is 839% — a market-crushing outperformance compared to 164% for the S&P 500.

Consider when Nvidia made this list on April 15, 2005 ... if you invested $ 1,000 at the time of our recommendation, you’d have $ 721,394 !.

VR Score

67

Informative language

69

Neutral language

18

Article tone

semi-formal

Language

English

Language complexity

44

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links